$VISM

VISIUM TECHNOLOGIES, INC.

CIK:0001082733|SEC Filings

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2026	Jun. 30, 2025
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$ 0	$ 0
Operating expenses:
Selling, general and administrative	1,364,165	1,649,817
Development expense	0	325
Total operating expenses	1,364,165	1,650,142
Loss from operations	(1,364,165)	(1,650,142)
Other income (expense)
Gain on change in fair value of derivative liabilities	271,391	33,761
Interest income	0	12,767
Interest expense	(765,013)	(463,424)
Gain on extinguishment of debt	2,923,004	725,059
Loss on terminated strategic acquisition initiative	(199,115)	0
Loss on write-off of advance for proposed financing	(10,000)	0
Total other income (expense)	2,220,267	308,163
Net income (loss) before income taxes	856,102	(1,341,979)
Provision for income taxes	0	0
Net income (loss)	856,102	(1,341,979)
Less: cumulative dividends on Series D Convertible Preferred Stock (undeclared)	(8,907)	0
Net income (loss) attributable to common stockholders	$ 847,195	$ (1,341,979)
Weighted average common shares
Basic	595,814,174	266,703,555
Diluted	616,444,868	266,703,555
Net income (loss) per common share attributable to common stockholders:
Net income (loss) per common share attributable to common stockholders Basic	$ 0.001	$ (0.005)
Net income (loss) per common share attributable to common stockholders Diluted	$ 0.001	$ (0.005)

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 856,102	$ (1,341,979)
Adjustments to reconcile net income to net cash used in operating activities:
Stock based compensation	352,150	384,260
Common stock issued for note conversion fees	3,500	0
Amortization of debt discount	420,524	67,194
Gain on change in fair value of derivative liability	(271,391)	(33,761)
Gain on extinguishment of debt	(2,923,004)	(725,059)
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	79,963	312,195
Accrued interest payable and default amounts added to note principal	201,260	363,323
Accrued compensation	367,548	570,150
Change in prepaid expenses	(540)	(7,500)
Net cash used in operating activities	(913,888)	(411,177)
Cash flows from financing activities:
Advances from officers and directors, net	85,500	95,225
Repurchase of warrants	(4,000)	0
Repayment of notes payable and convertible notes payable	(400,824)	(201,560)
Proceeds from sale of common stock	375,000	0
Proceeds from sale of preferred stock	300,000	0
Proceeds from short term note payable	528,000	569,200
Payment of debt issuance costs	(7,720)	0
Net cash provided by financing activities	875,956	462,865
Net increase (decrease) in cash	(37,932)	51,688
Cash at beginning of period	60,144	8,456
Cash at end of period	22,212	60,144
Cash paid for:
Interest	121,793	48,679
Income taxes	0	0
Noncash Investing and Financing Activities
Issuance of common stock for conversion of notes payable, accrued interest, and fees	317,035	265,823
Initial fair value of derivative liabilities recorded as debt discount	263,586	0
Original issue discount on notes payable	130,500	0
Commitment shares issued with notes payable (recorded as debt discount)	18,788	0
Promissory notes reclassified to convertible notes payable upon default	255,494	0
Issuance of common stock to settle accrued compensation and consulting fees ("salary equitization")	2,834,819	0
Liabilities extinguished in connection with Series D exchanges (including separately forgiven accrued interest)	1,724,089	0
Fair value of Series D Convertible Preferred Stock issued in debt-for-equity exchanges (see Note 7 and Note 9)	83,802	0
Debt issuance costs included in accounts payable	$ 5,800	$ 0

CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Current assets:
Cash	$ 22,212	$ 60,144
Prepaid expenses	8,040	7,500
Total current assets	30,252	67,644
Total assets	30,252	67,644
Current liabilities:
Accounts payable and accrued expenses	1,536,672	1,472,933
Accrued compensation	89,158	2,556,428
Accrued interest	125,116	418,044
Due to officers and directors	0	277,859
Convertible notes payable	108,009	183,873
Derivative liabilities	0	7,805
Notes payable	122,589	991,567
Total current liabilities	1,981,544	5,908,509
Commitments and contingencies (Note 14)	0	0
Stockholders' deficit:
Common stock, $0.0001 par value, 3,000,000,000 shares authorized: 1,149,509,667 shares issued and outstanding at June 30, 2026, and 368,544,861 shares issued and outstanding at June 30, 2025	114,953	36,856
Additional paid in capital	61,068,001	58,196,429
Accumulated deficit	(63,233,368)	(64,089,470)
Total stockholders' deficit	(2,035,094)	(5,840,865)
Total liabilities, temporary equity and stockholders' deficit	30,252	67,644
Series A Convertible Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	13,992	13,992
Series B Convertible Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	1,328	1,328
Series AA Convertible Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	0	0
Series D Convertible Preferred Stock [Member]
Stockholders' deficit:
Temporary equity, vaue	$ 83,802	$ 0